Is Edap Tms S.a. (EDAP) a Buy, Sell, or Hold?
NASDAQ : EDAP
Edap Tms S.a.
$4.755 USD
-$0.03 (-0.52%)
- Volume
- 28.86K
- Average Volume
- 39.24K
- Market Capitalization
- $178.23M
- P/E Ratio
- -6.18
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $5.05
- Year Low
- $1.21
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.34
| Source | Headline |
|---|---|
|
Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion
Edap Tms NASDAQ: EDAP used its 2026 FocalTherics Investor Day to outline its shift toward becoming a “high-growth, pure-play robotic focal therapy company,” with management emphasizing the company's Focal One robotic high-intensity focused ultrasound, or HIFU, platform for prostate cancer and future indications. marketbeat.com - 2026-06-01 15:06:01 |
|
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
, May 29, 2026 (GLOBE NEWSWIRE) -- EDAP Announces Corporate Name Change to FocalTherics ™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy globenewswire.com - 2026-05-29 07:30:00 |
|
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
, May 29, 2026 (GLOBE NEWSWIRE) -- EDAP Announces Corporate Name Change to FocalTherics to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy Company will Begin Trading Under New Ticker Symbol "FOCL" at Market Open on June 1, 2026Company Intends to Report and Classify its Legacy Non-Core ESWL and Distribution Operating Segments as Discontinued Operations Beginning with Second Quarter 2026 Financial ResultsInvestor Day to be Held on June 1, 2026 to Highlight Company Vision and Long-Term Strategy under New FocalTherics Corporate Identity AUSTIN, Texas, May 29, 2026 - EDAP TMS S. globenewswire.com - 2026-05-29 07:30:00 |
|
EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
, May 21, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference globenewswire.com - 2026-05-21 07:30:00 |
|
EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer
, May 14, 2026 (GLOBE NEWSWIRE) -- AUSTIN, Texas – May 14, 2026 – EDAP TMS S.A. (Nasdaq: EDAP) today announced that it has entered into a letter of intent with Telix Pharmaceuticals Limited (“Telix”) to explore joint clinical research activities and physician education focused on the combination of EDAP's Focal One Robotic HIFU and Telix's PSMA PET imaging products in the management of prostate cancer. globenewswire.com - 2026-05-14 07:30:00 |
|
EDAP | Focal One to Host Investor Day on June 1, 2026
, May 13, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Host Investor Day on June 1, 2026 AUSTIN, Texas, May 13, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (the "Company"), the global leader in robotic energy-based therapies, today announced that it will host an Investor Day for analysts and investors at 8:00 am ET on Monday, June 1, 2026. globenewswire.com - 2026-05-13 16:30:00 |
|
EDAP | Focal One to Host Investor Day on June 1, 2026
, May 13, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Host Investor Day on June 1, 2026 AUSTIN, Texas, May 13, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy-based therapies, today announced that it will host an Investor Day for analysts and investors at 8:00 am ET on Monday, June 1, 2026. The presentation will be led by members of the Company's Executive Leadership Team and will include remarks from a prominent urologic surgeon and expert in focal therapy and Focal One HIFU. globenewswire.com - 2026-05-13 16:30:00 |
|
EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript
EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-07 18:41:18 |
|
EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue
, May 07, 2026 (GLOBE NEWSWIRE) -- EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue globenewswire.com - 2026-05-07 07:30:00 |
|
EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer
, April 30, 2026 (GLOBE NEWSWIRE) -- EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One ® Robotic HIFU in Radiorecurrent Prostate Cancer globenewswire.com - 2026-04-30 08:30:00 |
